Tag: adjunctive treatment

Ozone therapy in COVID-19: A narrative review

This 2021 narrative review titled “Ozone therapy in COVID-19: A narrative review” (Virus Research, DOI: [10.1016/j.virusres.2020.198207*) assessed the potential role of ozone therapy as an adjunctive treatment for COVID-19. The authors discussed how ozone’s antiviral, anti-inflammatory, immunomodulatory, and oxygenation-enhancing properties could theoretically target key pathophysiological processes like cytokine storms and

Read More »

Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease

This randomized controlled trial investigated the use of curcuminoids, compounds derived from turmeric, in patients with oral lichen planus (OLP), a chronic autoimmune condition affecting the oral mucosa. The study found that curcuminoid treatment significantly reduced OLP symptoms compared to baseline, with no major adverse effects reported, indicating good tolerability.

Read More »

Pharmacological Treatment of Patients With Chronic Critical Limb Ischemia: L-propionyl-carnitine Enhances the Short-Term Effects of PGE-1

This randomized controlled trial investigated the effects of L-propionyl-carnitine (LPC) combined with prostaglandin E1 (PGE-1) on patients with chronic critical limb ischemia (CLI). The study showed that LPC enhanced the short-term effects of PGE-1, suggesting potential therapeutic benefits for CLI patients. However, the study did not provide detailed statistical results

Read More »